Balaji Amines Ltd reported consolidated revenue from operations of Rs 3.31 billion and net profit of Rs 314.3 million for the December quarter. The results highlight steady demand in specialty chemicals and pharmaceuticals, supported by operational efficiency and resilience in a competitive global chemical industry.
Balaji Amines Ltd, a leading manufacturer of specialty chemicals and pharmaceutical intermediates, announced its financial results for the December quarter. The company posted consolidated revenue from operations at Rs 3.31 billion, while net profit stood at Rs 314.3 million. The performance reflects consistent demand across key product categories and disciplined cost management.
Key highlights
-
Consolidated revenue from operations stood at Rs 3.31 billion in Q3.
-
Net profit reported at Rs 314.3 million.
-
Performance supported by steady demand in specialty chemicals and pharma intermediates.
-
Operational efficiency and disciplined cost management contributed to profitability.
-
Company continues to focus on expanding product portfolio and strengthening export markets.
-
Industry analysts view results as stable despite global chemical sector challenges.
Balaji Amines’ results underscore its ability to maintain profitability while navigating volatile raw material prices and global demand fluctuations. With a strong focus on innovation and market diversification, the company remains well-positioned to sustain growth in India’s specialty chemical industry.
Sources: Reuters, Economic Times, Business Standard